Financial News
Latest News about AMGN
Recent news which mentions AMGN
Why Vera Therapeutics Stock Soared by 22% This Week
January 12, 2024
From Motley Fool
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
January 11, 2024
From Benzinga
AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains
January 11, 2024
From Benzinga
Dogs of the Dow: January’s Top 3 Picks to Buy for Big Gains
January 10, 2024
From InvestorPlace
Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference
January 10, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 08, 2024
From Benzinga
From Benzinga
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2024
From Benzinga
Revenge of the Boring Stocks! Dividends Are Sexy Again.
January 03, 2024
From InvestorPlace
Dogs Of The Dow: Top 10 Highest Yielding Dow Jones Stocks, How To Get Dividends Of 3% to 7.4% In 2024
January 02, 2024
From Benzinga
3 Top ETFs I'm Planning to Buy Hand Over Fist in 2024, Despite All the Cheap Stocks on My Radar
January 01, 2024
From Motley Fool
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
December 29, 2023
From Motley Fool
Amgen's Options: A Look at What the Big Money is Thinking
December 28, 2023
Tickers
AMGN
From Benzinga
Full Approval For Amgen's Flagship Cancer Drug Lumakras Pushed For Around Four Years
December 26, 2023
From Benzinga
Analyzing Amgen In Comparison To Competitors In Biotechnology Industry
December 25, 2023
From Benzinga
Spotlight on Amgen: Analyzing the Surge in Options Activity
December 21, 2023
Tickers
AMGN
From Benzinga
3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’
December 21, 2023
From InvestorPlace
CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief
December 20, 2023
From InvestorPlace
Amgen Provides Exposure To Obesity Drug At A Reasonable Price, Says Bullish Analyst
December 19, 2023
Tickers
AMGN
From Benzinga
In-Depth Examination Of 18 Analyst Recommendations For Amgen
December 19, 2023
Tickers
AMGN
From Benzinga
Uber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday
December 19, 2023
From Benzinga
1 Biotech Stock That Could Be the Next Amgen
December 13, 2023
From Motley Fool
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?
December 12, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
